EUVIMEDEUVIMED entdecken
Open Access

Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females

Yijian Fan, Rui Jin iD, Lenore Monterroza iD, Xiuju Liu, Chunzi Huang, Angelo Marra iD, Xiulei Mo iD, Haian Fu iD, Melissa Gilbert-Ross iD, Adam I Marcus iD, Rabindra Tirouvanziam iD, Yuan Liu iD und 2 weitere

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djaf138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Yijian Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Killer Cells, Natural, Lung Neoplasms, Adenocarcinoma of Lung, Protein Serine-Threonine Kinases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Winship Invest$Team Science, NIA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study addressed the enigma of sex differences in smoking-related lung cancer, particularly focusing on the low LKB1 mutation frequency in female patients with lung adenocarcinoma.

Methods

Sex bias was studied with a genetically engineered mouse model and various tail-vein injection models. Immune cells were analyzed by antibody-depletion study, flow cytometry, and immunofluorescence. The relevance of our findings to human disease was validated by evaluating various lung adenocarcinoma datasets. All statistical tests are 2-sided.

Results

A statistically significant percentage of females are resistant to LKB1-mutant tumor formation in our models, reflecting this sex difference in humans. Natural killer (NK) cells were identified as a critical factor in this sex-biased response. This sex difference was observed primarily in LKB1-mutant lung adenocarcinoma, probably due to their low major histocompatibility complex class I level, making them the ideal target for NK cells through the missing-self recognition. Although females resistant to LKB1-mutant lung adenocarcinoma formation did not have enhancement of any specific NK subpopulation, our immunofluorescence analysis revealed high numbers of NKs in female lungs even with the presence of LKB1-mutant lung adenocarcinoma. Our gene set enrichment analysis of The Cancer Genome Atlas–lung adenocarcinoma dataset also showed that female LKB1-mutant lung adenocarcinoma patients have a stronger NK-mediated response after adjusting for other male-female differences using the LKB1 wild–type lung adenocarcinoma dataset.

Conclusion

Females have a stronger NK-mediated response against LKB1-mutant lung adenocarcinoma, which was present in our mouse model and the human lung adenocarcinoma dataset. This study revealed a novel role of NK cells in suppressing LKB1-mutant lung adenocarcinoma in females, which should be assessed in the clinical setting in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalLung NeoplasmsAdenocarcinoma of LungProtein Serine-Threonine KinasesAnimalsFemaleHumansMiceAMP-Activated Protein Kinase KinasesMaleMutationDisease Models, AnimalSex FactorsAMP-Activated Protein Kinases

Substanzen

AMP-Activated Protein Kinase KinasesProtein Serine-Threonine KinasesSTK11 protein, humanStk11 protein, mouseAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
  • Cancer Animal Models Shared Resource of Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States.
  • Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, GA, United States.
  • Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.

ORCID-Profile: Rui Jin, Lenore Monterroza, Angelo Marra, Xiulei Mo, Haian Fu, Melissa Gilbert-Ross, Adam I Marcus, Rabindra Tirouvanziam, Yuan Liu, Wei Zhou

Förderung

  • Winship Invest$Team Science
  • NIA NIH HHS
  • NCI NIH HHS
  • NCI Lung Cancer Spore
  • Career Enhancement Core
  • NIH
  • Career Enhancement Program
  • Winship shared resources

Zitieren

APA

Fan, Y., Jin, R., Monterroza, L., Liu, X., Huang, C., Marra, A., Mo, X., Fu, H., Gilbert-Ross, M., Marcus, A. I., Tirouvanziam, R., Liu, Y., Schneider, F., & Zhou, W. (2025). Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf138

Vancouver

Fan Y, Jin R, Monterroza L, Liu X, Huang C, Marra A, et al. Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf138

BibTeX
@article{Fan2025,
  author = {Fan, Yijian and Jin, Rui and Monterroza, Lenore and Liu, Xiuju and Huang, Chunzi and Marra, Angelo and Mo, Xiulei and Fu, Haian and Gilbert-Ross, Melissa and Marcus, Adam I and Tirouvanziam, Rabindra and Liu, Yuan and Schneider, Frank and Zhou, Wei},
  title = {Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djaf138}
}
Kostenlos starten →